Instituto Bioclon
id:
instituto-bioclon-269-8287497
title:
Instituto Bioclon
text:
The Instituto Bioclon S.A. de C.V. was formed in 1990 to research and develop F(ab’)2 antivenoms. On May 6, 2015 they received approval from the FDA to commercialize Anavip becoming their second drug approved by the FDA after ANASCORP. Both are commercialized in the US by Rare Disease Therapeutics, Inc. The company is performing clinical trials to get approval for a third drug, ANALATRO, designed to treat black widow spider envenomation.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Instituto_Bioclon
date created:
date modified:
2023-08-24T05:41:23Z
main entity:
{"identifier":"Q6041278","url":"https://www.wikidata.org/entity/Q6041278"}
image:
fields total:
13
integrity:
13